Breast cancer drug pushes colon cancer cells to their death
2011-06-09
(Press-News.org) A new treatment for colon cancer that combines a chemotherapy agent approved to treat breast cancer and a cancer-fighting antibody is ready for clinical trials, according to Penn State College of Medicine researchers.
More than 150,000 cases of colorectal cancer are diagnosed each year, and about 50,000 people die from colorectal cancer yearly. Currently there are limited chemotherapy treatments for colorectal cancer with little that has been in the pipeline in recent years.
Wafik S. El-Deiry, M.D. Ph.D., American Cancer Society Research Professor and Rose Dunlap Professor and chief of hematology/oncology, and his team have tested lapatinib, a targeted chemotherapy agent currently approved for breast cancer treatment, in a new combination with artificial antibodies that mimic a natural cancer-fighting protein produced in the human body. The monoclonal antibodies mapatumumab and lexatumumab act similarly to TRAIL -- tumor necrosis factor [TNF]-related apoptosis-inducing ligand -- a naturally occurring molecule in the body that tells a cell it is time to die. TRAIL sets a process in motion that targets and shuts down tumor cells and keeps them from spreading.
"These are therapeutic antibodies that are manufactured very efficiently, and given to patients," said El-Deiry, who is also the associate director for translational research, Cancer Institute.
The TRAIL receptors -- death receptors -- on the cancer cells respond to TRAIL by dying. The artificial antibodies act as surrogates of TRAIL by activating the same signaling pathway resulting in tumor cell death.
The monoclonal antibodies have an advantage over TRAIL because they remain active in the body for a longer period of time. TRAIL receptor antibodies last for less than 30 minutes, while the artificial monoclonal antibodies last for about nine days. Although the antibodies can act similarly to TRAIL, they do not completely substitute for TRAIL and ultimately which one gets used in what situation is still being tested in clinical trials. But for the purpose of these new advances either one works.
Lapatinib increases the amount of "death receptor" protein available for TRAIL to do its job -- killing off cancerous cells -- El-Deiry and his colleagues report in this week's issue of Science Translational Medicine.
The researchers tested the lapatinib and monoclonal antibody combination in mice. Separately, the two treatments did not increase tumor cell suppression -- but when the drugs were administered together, the researcher found that cell death escalated.
"We have discovered a mechanistic basis for combining these drugs that says one drug upregulates the receptor for the other drug, and maybe now when we combine these two drugs we'll get an even better synergy between them," said El-Deiry. "I think that's probably the most exciting result, to be able to provide a molecular rationale for a new treatment combination for difficult-to-treat advanced colorectal cancers."
The Food and Drug Administration approved lapatinib in 2007 for use as a breast cancer chemotherapy. It blocks two specific types of proteins located on tumor cell surfaces from causing tumors to grow. These proteins are a potent way that tumors are signaled to grow -- and if the proteins are blocked, there is one less mechanism for tumors to proliferate. However, in the treatment El-Deiry has proposed, lapatinib would be used off-label by increasing a different tumor cell death-inducing protein to help colon cancer patients.
### Also working on this research were Nathan G. Dolloff, Ph.D; Patrick A. Mayes, Ph.D.; Lori S. Hart, Ph.D.; David T. Dicker, technical specialist; and Robin Humphreys, Human Genome Sciences.
The National Institutes of Health supported this research.
ELSE PRESS RELEASES FROM THIS DATE:
Water's surface not all wet
2011-06-09
Air and water meet over most of the earth's surface, but exactly where one ends and the other begins turns out to be a surprisingly subtle question.
A new study in Nature narrows the boundary to just one quarter of water molecules in the uppermost layer – those that happen to have one hydrogen atom in water and the other vibrating freely above.
Such molecules straddle gas and liquid phases, according to senior author Alexander Benderskii of the University of Southern California: The free hydrogen behaves like an atom in gas phase, while its twin below acts much like ...
Two Exciting Workshops Being Held in Conjunction With the 2011 STEMtech Conference
2011-06-09
The League for Innovation in the Community College has announced that two exciting workshops will be offered in conjunction with the 2011 STEMtech conference being held October 2-5, at the JW Marriott Indianapolis. Educators, industry leaders, and others will gather to discuss increasing student access into and success in science, technology, engineering, and mathematics (STEM) majors and careers. The 2011 STEMtech conference will also help educators explore the strategic use of information technology to better serve their students, campuses, and communities. Complete conference ...
Caltech-led astronomers find a new class of stellar explosions
2011-06-09
PASADENA, Calif.-They're bright and blue-and a bit strange. They're a new type of stellar explosion that was recently discovered by a team of astronomers led by the California Institute of Technology (Caltech). Among the most luminous in the cosmos, these new kinds of supernovae could help researchers better understand star formation, distant galaxies, and what the early universe might have been like.
"We're learning about a whole new class of supernovae that wasn't known before," says Robert Quimby, a Caltech postdoctoral scholar and the lead author on a paper to be ...
Einstein scientists find crucial molecule involved in spread of breast cancer
2011-06-09
June 8, 2011 — (Bronx, NY) — Researchers at Albert Einstein College of Medicine of Yeshiva University have identified a key player in the spread of breast cancer. The findings, published today in the online edition of Nature, identify a critical molecule that helps cancer spread beyond the primary tumor. The research highlights a potential new strategy against metastatic disease. The study's senior author is Jeffrey Pollard, Ph.D., professor of developmental and molecular biology and of obstetrics & gynecology and women's health at Einstein. He also holds the Louis Goldstein ...
New data adds to the hunt for dark matter in the universe
2011-06-09
This week it was announced that a dark matter detector about 700 meters below the ground in a Minnesota mine has recorded a seasonal modulation in staggeringly faint electrical pulses. One possible reason: this could be the result of dark matter particles called WIMPs that envelope the Milky Way galaxy and collide with atoms in the detector's germanium crystal.
This seems possible because the results are consistent with modulation in signals first recorded more than a decade ago by the DArk MAtter/Large sodium Iodide Bulk for RAre processes (DAMA/LIBRA) experiment at ...
The same type of forest is good for both birds and people
2011-06-09
Birds and people both enjoy urban woodlands that have been cleared to just the right degree. This is the conclusion of scientists at the University of Gothenburg who have carried out large-scale field experiments in urban woodlands in south-western Sweden.
"Three out of four people want a mixture of open and untouched forest for rambling. At the same time, we can see that birds do well and continue to nest in woodlands where less than 50% has been cleared", says Erik Heyman of the Department of Plant and Environmental Sciences at the University of Gothenburg.
The natural ...
Turnberry Tower Condominium Enclave Set To Break Its Own Sales Records For 2011 in Washington DC Area
2011-06-09
Named "The Height of Luxury" by The Washington Post, Turnberry Tower was the Washington, DC-area's top-selling luxury condominium project in 2010. The ultra-luxury residential tower is breaking records again in 2011, with $70 million in new sales to date this year -- at an average price of over $1.3 million. This places Turnberry Vice President of Sales and Marketing, Dan Riordan, with a spectacular view of Turnberry Tower's future as the area's tallest residential condominium project. The 26-story, sapphire-blue spire is a beacon adjacent to the Key Bridge, offering ...
Swine flu spread was much wider than first thought, scientists say
2011-06-09
The swine flu outbreak of winter 2009-2010 was much more widespread than was previously realised, research suggests.
Blood samples taken from Scottish adults in March last year at the end of the H1N1 flu season showed that almost half were carrying antibodies to the virus.
Most of the 44 per cent who tested positive had contracted swine flu, although some had acquired immunity from a previous bout of flu, or had been vaccinated.
The research, led by the University of Edinburgh, shows that many cases of swine flu went unreported. Only 100,000 people consulted their ...
MyCare -- the 'card' that could save your life
2011-06-09
It looks like a credit card…it slips into a wallet or purse…but it could mean the difference between life and death in a medical emergency.
The MyCare Card stores personal medical data (e.g. information on existing medical conditions, allergies and medication being taken) and plugs into a laptop's USB port, enabling the data to be accessed in just a few moments.
It is the first device of its type to have been trialled in the UK.
This working prototype has been developed by City University London and Coventry University, with funding from the Engineering and Physical ...
Glaciations may have larger influence on biodiversity tan current climate
2011-06-09
The study, published yesterday in the journal Ecology Letters, analyzed the species richness and the structure of their communities throughout the different regions of the European territory from the Ural Mountains to the Iberian Peninsula. The selection of this family of insects was motivated by their high dispersal ability and because their food sources (mainly cattle and sheep dung) are present throughout the continent.
Research by the Spanish National Research Council reveals that the large impacts occurred during the last ice age maintain their
effects on the current ...